Back to Search Start Over

Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis.

Authors :
Cortese R
Battaglini M
Prados F
Gentile G
Luchetti L
Bianchi A
Haider L
Jacob A
Palace J
Messina S
Paul F
Marignier R
Durand-Dubief F
de Medeiros Rimkus C
Apostolos Pereira SL
Sato DK
Filippi M
Rocca MA
Cacciaguerra L
Rovira À
Sastre-Garriga J
Arrambide G
Liu Y
Duan Y
Gasperini C
Tortorella C
Ruggieri S
Amato MP
Ulivelli M
Groppa S
Grothe M
Llufriu S
Sepulveda M
Lukas C
Bellenberg B
Schneider R
Sowa P
Celius EG
Pröbstel AK
Granziera C
Yaldizli Ö
Müller J
Stankoff B
Bodini B
Barkhof F
Ciccarelli O
De Stefano N
Source :
Annals of neurology [Ann Neurol] 2024 Aug; Vol. 96 (2), pp. 276-288. Date of Electronic Publication: 2024 May 23.
Publication Year :
2024

Abstract

Objective: To evaluate: (1) the distribution of gray matter (GM) atrophy in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4+NMOSD), and relapsing-remitting multiple sclerosis (RRMS); and (2) the relationship between GM volumes and white matter lesions in various brain regions within each disease.<br />Methods: A retrospective, multicenter analysis of magnetic resonance imaging data included patients with MOGAD/AQP4+NMOSD/RRMS in non-acute disease stage. Voxel-wise analyses and general linear models were used to evaluate the relevance of regional GM atrophy. For significant results (p < 0.05), volumes of atrophic areas are reported.<br />Results: We studied 135 MOGAD patients, 135 AQP4+NMOSD, 175 RRMS, and 144 healthy controls (HC). Compared with HC, MOGAD showed lower GM volumes in the temporal lobes, deep GM, insula, and cingulate cortex (75.79 cm <superscript>3</superscript> ); AQP4+NMOSD in the occipital cortex (32.83 cm <superscript>3</superscript> ); and RRMS diffusely in the GM (260.61 cm <superscript>3</superscript> ). MOGAD showed more pronounced temporal cortex atrophy than RRMS (6.71 cm <superscript>3</superscript> ), whereas AQP4+NMOSD displayed greater occipital cortex atrophy than RRMS (19.82 cm <superscript>3</superscript> ). RRMS demonstrated more pronounced deep GM atrophy in comparison with MOGAD (27.90 cm <superscript>3</superscript> ) and AQP4+NMOSD (47.04 cm <superscript>3</superscript> ). In MOGAD, higher periventricular and cortical/juxtacortical lesions were linked to reduced temporal cortex, deep GM, and insula volumes. In RRMS, the diffuse GM atrophy was associated with lesions in all locations. AQP4+NMOSD showed no lesion/GM volume correlation.<br />Interpretation: GM atrophy is more widespread in RRMS compared with the other two conditions. MOGAD primarily affects the temporal cortex, whereas AQP4+NMOSD mainly involves the occipital cortex. In MOGAD and RRMS, lesion-related tract degeneration is associated with atrophy, but this link is absent in AQP4+NMOSD. ANN NEUROL 2024;96:276-288.<br /> (© 2024 The Author(s). Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.)

Details

Language :
English
ISSN :
1531-8249
Volume :
96
Issue :
2
Database :
MEDLINE
Journal :
Annals of neurology
Publication Type :
Academic Journal
Accession number :
38780377
Full Text :
https://doi.org/10.1002/ana.26951